ENDOMETRIAL CANCER STAGE IV

This adverse event was reported 37 times

These drugs are most commonly taken by patients reporting ENDOMETRIAL CANCER STAGE IV:

# Drug Count
0 CARBOPLATIN 8
1 PACLITAXEL 7
2 PACLITAXEL (AIBUMIN-BOUND) 7
3 DOSTARLIMAB 4
4 ETANERCEPT 2
5 HYDROXYCHLOROQUINE SULFATE 2
6 METOPROLOL 2
7 METOPROLOL TARTRATE 2
8 PREDNISONE 2
9 TESTOSTERONE 2
See all common drugs associated with ENDOMETRIAL CANCER STAGE IV

ENDOMETRIAL CANCER STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DOSTARLIMAB 4 0.0016
1 UBLITUXIMAB 2 0.0005
2 MINOCYCLINE HYDROCHLORIDE 1 0.0002
3 PHYTONADIONE 1 0.0001
4 NIACIN 1 0.0001
5 MINOCYCLINE 1 0.0001
6 TESTOSTERONE 2 0.0001
7 PACLITAXEL 7 0.0001
8 CARBOPLATIN 8 0.0001
9 VORTIOXETINE 1 0.0001
See all drugs enriched for association with ENDOMETRIAL CANCER STAGE IV